William Blair Comments on Amedisys, Inc.’s FY2024 Earnings (NASDAQ:AMED)

Amedisys, Inc. (NASDAQ:AMED) – Equities researchers at William Blair raised their FY2024 EPS estimates for Amedisys in a research note issued to investors on Thursday, April 25th. William Blair analyst M. Larew now expects that the health services provider will earn $4.54 per share for the year, up from their previous estimate of $4.37. The consensus estimate for Amedisys’ current full-year earnings is $4.58 per share.

AMED has been the topic of a number of other reports. Raymond James reaffirmed a “market perform” rating on shares of Amedisys in a research note on Tuesday, March 26th. StockNews.com lowered shares of Amedisys from a “buy” rating to a “hold” rating in a research note on Friday. Cantor Fitzgerald reaffirmed a “neutral” rating and issued a $101.00 price target on shares of Amedisys in a research note on Thursday. Finally, Royal Bank of Canada raised their price target on shares of Amedisys from $97.00 to $100.00 and gave the company an “outperform” rating in a research note on Monday, March 25th. Eight analysts have rated the stock with a hold rating and one has given a buy rating to the stock. According to data from MarketBeat.com, the stock has an average rating of “Hold” and an average price target of $97.50.

Amedisys Trading Up 0.7 %

AMED stock opened at $91.79 on Monday. The company’s 50-day simple moving average is $92.54 and its 200-day simple moving average is $93.36. The company has a quick ratio of 1.05, a current ratio of 1.05 and a debt-to-equity ratio of 0.32. Amedisys has a 52-week low of $73.10 and a 52-week high of $96.44. The firm has a market cap of $3.00 billion, a P/E ratio of -143.42, a PEG ratio of 4.32 and a beta of 0.86.

Amedisys (NASDAQ:AMED) last posted its earnings results on Wednesday, April 24th. The health services provider reported $1.03 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.02 by $0.01. Amedisys had a negative net margin of 0.91% and a positive return on equity of 13.00%. The business had revenue of $571.41 million for the quarter, compared to analyst estimates of $565.38 million. During the same period in the prior year, the company posted $1.00 EPS. The company’s revenue for the quarter was up 2.7% on a year-over-year basis.

Institutional Investors Weigh In On Amedisys

Several institutional investors have recently modified their holdings of AMED. Exchange Traded Concepts LLC purchased a new stake in shares of Amedisys during the 3rd quarter worth $609,000. Commonwealth Equity Services LLC raised its stake in Amedisys by 2.9% during the 3rd quarter. Commonwealth Equity Services LLC now owns 3,896 shares of the health services provider’s stock worth $364,000 after acquiring an additional 110 shares in the last quarter. Xponance Inc. raised its stake in Amedisys by 3.2% during the 3rd quarter. Xponance Inc. now owns 4,076 shares of the health services provider’s stock worth $381,000 after acquiring an additional 125 shares in the last quarter. Zurcher Kantonalbank Zurich Cantonalbank raised its stake in Amedisys by 12.7% during the 3rd quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 5,893 shares of the health services provider’s stock worth $550,000 after acquiring an additional 663 shares in the last quarter. Finally, ING Groep NV raised its stake in Amedisys by 257.4% during the 3rd quarter. ING Groep NV now owns 189,800 shares of the health services provider’s stock worth $17,727,000 after acquiring an additional 136,700 shares in the last quarter. 94.36% of the stock is owned by hedge funds and other institutional investors.

About Amedisys

Amedisys, Inc, together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; nursing services, rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients.